A pilot open label prospective study of memantine monotherapy in adults with ADHD

References

• Arnsten AF. 2006. Stimulants: Therapeutic actions in ADHD. Neuropsychopharmacology 31:2376–2383.
   PubMed Web of Science ®Google Scholar
• Biederman J, Spencer T. 1999. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry 46: 1234–1242.
   PubMed Web of Science ®Google Scholar
• Biederman J, Faraone SV, Spencer T, Wilens T, Mick E, Lapey KA. 1994. Gender differences in a sample of adults with attention deficit hyperactivity disorder. Psychiatry Res 53:13–29.
   PubMed Web of Science ®Google Scholar
• Biederman J, Faraone SV, Spencer T, Mick E, Monuteaux M, Aleardi M. 2006a. Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community. J Clin Psychiatry 67:524–540.
   PubMed Web of Science ®Google Scholar
• Biederman J, Petty C, Fried R, Fontanella J, Doyle AE, Seidman LJ, et al. 2006b. Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 163: 1730–1738.
   PubMed Web of Science ®Google Scholar
• Biederman J, Petty CR, Fried R, Doyle AE, Spencer T, Seidman LJ, et al. 2007. Stability of executive function deficits into young adult years: a prospective longitudinal follow-up study of grown up males with ADHD. Acta Psychiatr Scand 116: 129–136.
   PubMed Web of Science ®Google Scholar
• Biederman J, Petty CR, Fried R, Black S, Faneuil A, Doyle AE, et al. 2008a. Discordance between psychometric testing and questionnaire-based definitions of executive function deficits in individuals with ADHD. J Atten Disord 12:92–102.
   PubMed Web of Science ®Google Scholar
• Biederman J, Seidman LJ, Petty CR, Fried R, Doyle AE, Cohen DR, et al. 2008b. Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 69:1150–1156.
   PubMed Web of Science ®Google Scholar
• Breier A, Adler CM, Weisenfeld N, Su TP, Elman I, Picken L, et al. 1998. Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach. Synapse 29:142–147.
   PubMedGoogle Scholar
• Bush G, Shin LM, Holmes J, Rosen BR and Vogt BA. 2003. The Multi–Source Interference Task: validation study with fMRI in individual subjects. Mol Psychiatry 8:60–70.
   PubMed Web of Science ®Google Scholar
• Cambridge Cognition Limited. 2004. CANTABeclipse Test Administration Guide.
   Google Scholar
• Cochrane A, Barnes-Holmes D, Barnes-Holmes Y, Stewart I, Luciano C. 2007. Experiential avoidance and aversive visual images: Response delays and event-related potentials on a simple matching task. Behav Res Ther 45:1379–1388.
   Google Scholar
• Delis D, Kaplan E, Kraemer JH. 2001. Delis-Kaplan executive function system (D-KEFS). San Antonio, Texas, USA: The Psychological Corporation.
   Google Scholar
• Fan J, McCandliss BD, Sommer T, Raz A and Posner MI. 2002. Testing the efficiency and independence of attentional networks. J Cogn Neurosci 14:340–7.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Biederman J, Doyle A, Murray K, Petty C, Adamson JJ, et al. 2006. Neuropsychological studies of late onset and subthreshold diagnoses of adult attention-deficit/hyperactivity disorder. Biol Psychiatry 60:1081–1087.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, et al. 2000. Attention deficit hyperactivity disorder in adults: an overview. Biol Psychiatry 48:9–20.
   PubMed Web of Science ®Google Scholar
• Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, et al. 2007. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 190:402–409.
   PubMed Web of Science ®Google Scholar
• Findling RL, McNamara NK, Stansbrey RJ, Maxhimer R, Periclou A, Mann A, et al. 2007. A pilot evaluation of the safety, tolerability, pharmacokinetics, and effectiveness of memantine in pediatric patients with attention-deficit/hyperactivity disorder combined type. J Child Adolesc Psychopharmacol 17:19–33.
   PubMed Web of Science ®Google Scholar
• First M, Spitzer R, Gibbon M, Williams J. 1997. Structured Clinical Interview for DSM-IV Axis I Disorders. Washington, DC: American Psychiatric Press.
   Google Scholar
• Jensen V, Rinholm JE, Johansen TJ, Medin T, Storm-Mathisen J, Sagvolden T, et al. 2009. N-Methyl-D-aspartate receptor subunit dysfunction at hippocampal glutamatergic synapses in an animal model of attention-deficit/hyperactivity disorder. Neuroscience 158:353–364.
   Google Scholar
• Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. 2006. The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. Am J Psychiatry 163:716–23.
   PubMed Web of Science ®Google Scholar
• Kotecha SA, Oak JN, Jackson MF, Perez Y, Orser BA, Van Tol HH, et al. 2002. A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission. Neuron 35:1111–1122.
   PubMed Web of Science ®Google Scholar
• Logan GD. 1994. A users guide to the stop signal paradigm. In: Inhibitory processes in attention, memory and language. San Francisco, CA: Academic Press. p. 189–239.
   Google Scholar
• Michelson D, Adler L, Spencer T, Reimherr FW, West SA, Allen AJ, et al. 2003. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 53: 112–120.
   PubMed Web of Science ®Google Scholar
• Murphy K, Barkley RA. 1996. Attention deficit hyperactivity disorder adults: Comorbidities and adaptive impairments. Compr Psychiatry 37:393–401.
   PubMed Web of Science ®Google Scholar
• Orvaschel H. 1994. Schedule for Affective Disorder and Schizophrenia for School-Age Children Epidemiologic Version. Ft. Lauderdale, FL: Nova Southeastern University, Center for Psychological Studies.
   Google Scholar
• Plosker GL, Lyseng-Williamson KA. 2005. Memantine: a pharmacoeconomic review of its use in moderate-to-severe Alzheimer's disease. Pharmacoeconomics 23:193–206.
   PubMed Web of Science ®Google Scholar
• Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. 2007. The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am J Psychiatry 164:942–948.
   PubMed Web of Science ®Google Scholar
• Rammsayer TH. 2006. Effects of pharmacologically induced changes in NMDA receptor activity on human timing and sensorimotor performance. Brain Res 1073–;1074:407–416.
   Google Scholar
• Roth R, Isquith P, Gioia G. 2005. BRIEF – A Behavior rating inventory of executive function-adult version, publication manual. Lutz: Psychological Assessment Resources, Inc.
   Google Scholar
• Seidman LJ, Doyle AE, Fried R, Valera E, Crum K and Matthews L. 2004. Neuropsychological function in adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 27: 261–282.
   PubMed Web of Science ®Google Scholar
• Smith GS, Schloesser R, Brodie JD, Dewey SL, Logan J, Vitkun SA, et al. 1998. Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects. Neuropsychopharmacology 18:18–25.
   PubMed Web of Science ®Google Scholar
• Turic D, Langley K, Mills S, Stephens M, Lawson D, Govan C, et al. 2004. Follow-up of genetic linkage findings on chromosome 16p13: Evidence of association of N-methyl-D aspartate glutamate receptor 2A gene polymorphism with ADHD. Mol Psychiatry 9:169–173.
   PubMedGoogle Scholar
• Verma A, Moghaddam B. 1996. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: Modulation by dopamine. J Neurosci 16:373–379.
   PubMed Web of Science ®Google Scholar
• Wanchoo SJ, Swann AC, Dafny N. 2009. Descending glutamatergic pathways of PFC are involved in acute and chronic action of methylphenidate. Brain Res 1301:68–79.
   PubMed Web of Science ®Google Scholar
• Warton FL, Howells FM, Russell VA. 2009. Increased glutamate-stimulated release of dopamine in substantia nigra of a rat model for attention-deficit/hyperactivity disorder – lack of effect of methylphenidate. Metab Brain Dis 24:599–613.
   Google Scholar
• Wechsler D. 1999. Wechsler Abbreviated Scale of Intelligence (WASI). San Antonio, TX: The Psychological Corporation.
   Google Scholar
• Wechsler D. 1997. Wechsler Adult Intelligence Scale III [manual]. San Antonio, TX: The Psychological Corporation.
   Google Scholar
• Wenk GL, Parsons CG, Danysz W. 2006. Potential role of N-methyl-D-aspartate receptors as executors of neurodegeneration resulting from diverse insults: Focus on memantine. Behav Pharmacol 17:411–424.
   PubMedGoogle Scholar
• Wilkinson GS. 1993. WRAT3 Wide Range Achievement Test: Administration Manual. Wilmington, DE: Wide Range, Inc.
   Google Scholar